New hope in the treatment of cancer, a new medicine worth Rs 21.5 lakh has been launched in India

American pharma company Eli Lilly has launched a new anti-cancer drug called Tansstrive in India. The drug, intended for patients with RET gene mutations, targets the underlying problem of cancer, but its cost has also been the subject of d